Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 192 publications.
Herring WL, Zhang Y, Pearson I, Tempest M, Freudensprung U, Acosta C, Hyde R, Spelman T, Butzkueven H. A cost-effectiveness analysis using real-world data from the MSBase registry: comparing natalizumab to fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis (RRMS) in Scotland. Poster presented at the 2018 American Academy of Neurology Annual Meeting; April 22, 2018. Previously presented at the 7th Joint ECTRIMS-ACTRIMS Meeting.

Pages